Haemonetics (HAE) Enterprise Value Growth (3y) (2012 - 2026)

Haemonetics (HAE) Enterprise Value Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Haemonetics 3.50 Bn 3.26 Bn 198.21 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 4.80%
Dec 27, 2025 -17.50%
Sep 27, 2025 -7.11%
Jun 28, 2025 -10.86%
Mar 29, 2025 -5.74%
Dec 28, 2024 -10.64%
Sep 28, 2024 -15.86%
Jun 29, 2024 -25.69%
Mar 30, 2024 2.40%
Dec 30, 2023 -0.87%
Sep 30, 2023 -7.93%
Jul 1, 2023 -1.19%
Apr 1, 2023 -27.48%
Dec 31, 2022 -21.01%
Oct 1, 2022 -29.13%
Jul 2, 2022 -4.16%
Apr 2, 2022 -15.29%
Jan 1, 2022 -15.22%
Oct 2, 2021 1.24%
Jul 3, 2021 3.35%